Multisystem inflammatory syndrome in children related to COVID-19: a systematic review

被引:265
|
作者
Hoste, Levi [1 ,2 ]
Van Paemel, Ruben [3 ,4 ,5 ]
Haerynck, Filomeen [1 ,2 ]
机构
[1] Ghent Univ Hosp, Dept Pediat Pulmonol Infect Dis & Immunol, Ghent, Belgium
[2] Ghent Univ Hosp, Primary Immunodeficiency Res Lab, Ctr Primary Immunodeficiency Ghent, Jeffrey Modell Diag & Res Ctr, Ghent, Belgium
[3] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium
[4] Canc Res Inst Ghent CRIG, Ghent, Belgium
[5] Ghent Univ Hosp, Dept Pediat Hematol Oncol & Stem Cell Transplanta, Ghent, Belgium
关键词
PIMS-TS; MIS-C; COVID-19; SARS-CoV-2; MIMICKING KAWASAKI-DISEASE; SARS-COV-2; PIMS-TS; MIS-C; INVOLVEMENT; SHOCK; INFECTION; DIAGNOSIS;
D O I
10.1007/s00431-021-03993-5
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
An association between a novel pediatric hyperinflammatory condition and SARS-CoV-2 was recently published and termed pediatric inflammatory multisystem syndrome, temporally associated with SARS-CoV-2 (PIMS-TS) or multisystem inflammatory syndrome (in children) (MIS(-C)). We performed a systematic review and describe the epidemiological, clinical, and prognostic characteristics of 953 PIMS-TS/MIS(-C) cases in 68 records. Additionally, we studied the sensitivity of different case definitions that are currently applied. PIMS-TS/MIS(-C) presents at a median age of 8 years. Epidemiological enrichment for males (58.9%) and ethnic minorities (37.0% Black) is present. Apart from obesity (25.3%), comorbidities are rare. PIMS-TS/MIS(-C) is characterized by fever (99.4%), gastrointestinal (85.6%) and cardiocirculatory manifestations (79.3%), and increased inflammatory biomarkers. Nevertheless, 50.3% present respiratory symptoms as well. Over half of patients (56.3%) present with shock. The majority of the patients (73.3%) need intensive care treatment, including extracorporal membrane oxygenation (ECMO) in 3.8%. Despite severe disease, mortality is rather low (1.9%). Of the currently used case definitions, the WHO definition is preferred, as it is more precise, while encompassing most cases. Conclusion: PIMS-TS/MIS(-C) is a severe, heterogeneous disease with epidemiological enrichment for males, adolescents, and racial and ethnic minorities. However, mortality rate is low and short-term outcome favorable. Long-term follow-up of chronic complications and additional clinical research to elucidate the underlying pathogenesis is crucial. What is Known: A novel pediatric inflammatory syndrome with multisystem involvement has been described in association with SARS-CoV-2. To date, the scattered reporting of cases and use of different case definitions provides insufficient insight in the full clinical spectrum, epidemiological and immunological features, and prognosis. What is New: This systematic review illustrates the heterogeneous spectrum of PIMS-TS/MIS(-C) and its epidemiological enrichment for males, adolescents, and racial and ethnic minorities. Despite its severe presentation, overall short-term outcome is good. The WHO MIS definition is preferred, as it is more precise, while encompassing most cases.
引用
收藏
页码:2019 / 2034
页数:16
相关论文
共 50 条
  • [31] Lung involvement in children with COVID-19 multisystem inflammatory syndrome
    Ghezzi, Michele
    Longoni, Emma
    Munari, Alice
    Raso, Irene
    Biganzoli, Giacomo
    Zuccotti, Gianvincenzo
    D'Auria, Enza
    PEDIATRIC PULMONOLOGY, 2023, 58 (02) : 615 - 618
  • [32] A Pregnant Adolescent with COVID-19 and Multisystem Inflammatory Syndrome in Children
    Trostle, Megan E.
    Grossman, Tracy B.
    Penfield, Christina A.
    Phoon, Colin K. L.
    Raabe, Vanessa N.
    Sloane, Mark F.
    Roman, Ashley S.
    AJP REPORTS, 2024, 14 (01): : e66 - e68
  • [33] Multisystem Inflammatory Syndrome in Children With COVID-19 in Mumbai, India
    Jain, Shreepal
    Sen, Supratim
    Lakshmivenkateshiah, Srinivas
    Bobhate, Prashant
    Venkatesh, Sumitra
    Udani, Soonu
    Shobhavat, Laxmi
    Andankar, Parmanand
    Karande, Tanuja
    Kulkarni, Snehal
    INDIAN PEDIATRICS, 2020, 57 (11) : 1015 - 1019
  • [34] Complexities of the COVID-19 vaccine and multisystem inflammatory syndrome in children
    Blumenthal, Jennifer A.
    Burns, Jeffrey P.
    PEDIATRIC INVESTIGATION, 2020, 4 (04) : 299 - 300
  • [35] COVID-19 Associated Multisystem Inflammatory Syndrome: A Systematic Review and Meta-analysis
    Baradaran, Ashkan
    Malek, Abdolreza
    Moazzen, Nasrin
    Shaye, Zahra Abbasi
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2020, 19 (06) : 570 - 588
  • [36] Multisystem inflammatory syndrome in children: another COVID-19 sequel
    Rassi, Christophe El
    Zareef, Rana
    Honeini, Rawan
    Latouf, Christelle
    Bitar, Fadi
    Arabi, Mariam
    CARDIOLOGY IN THE YOUNG, 2023, 33 (08) : 1418 - 1428
  • [37] Multisystem inflammatory syndrome in children: A unique manifestation of COVID-19
    Chan, Si Min
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2022, 51 (11) : 666 - 668
  • [38] Kawasaki Disease and Multisystem Inflammatory Syndrome in Children with COVID-19
    Mojdeh Sarzaeim
    Nima Rezaei
    SN Comprehensive Clinical Medicine, 2020, 2 (11) : 2096 - 2101
  • [39] Complexities of the COVID-19 vaccine and multisystem inflammatory syndrome in children
    Blumenthal Jennifer A
    Burns Jeffrey P
    儿科学研究(英文), 2020, 04 (04) : 299 - 300
  • [40] Multisystem inflammatory syndrome associated with COVID-19 in children in Pakistan
    Sadiq, Masood
    Aziz, Omeir Ali
    Kazmi, Uzma
    Hyder, Najam
    Sarwar, Muhammad
    Sultana, Nighat
    Bari, Attia
    Rashid, Junaid
    LANCET CHILD & ADOLESCENT HEALTH, 2020, 4 (10): : E36 - E37